The bi-partisan Drug Quality and Security Act passed the U.S. Senate Monday. It now goes to President Obama's desk to be signed into law.
The bill gives the Food and Drug Administration (FDA) more authority to oversee and regulate compound pharmacies. A lack of oversight is widely blamed for last fall's fungal meningitis outbreak that killed dozens of people nationwide, including five in Southwest Virginia.
In August, our investigation showed the company responsible, New England Compounding Center, repeatedly violated FDA rules but was allowed to keep operating for more than a decade.
Congressman Morgan Griffith (R-Salem) introduced the bill in the House of Representatives in September. He said this bill will make sure the proper checks are in place to prevent an outbreak from happening again.